Thubrikar Aortic Valve, Inc.
Our next-gen Transcatheter Aortic Valve Implantation (TAVI) system was designed for durability. It's shown preclinical superiority, and clinical feasibility.
Dr. Mano Thubrikar designed Optimum TAV after the natural aortic valve for maximum durability. The Company's Brazilian licensee started a clinical trial with our Optimum TAVI System (includes PRECISION delivery catheter) in 2018, and our Chinese licensee will start in 2019. Our licensees will provide ongoing clinical data (and royalties). Preclinical superiority shown (e.g. 24 years in durability test, less pressure gradient in sheep).